These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 27181083)
21. Molecular genetics approaches in yeast to study amyloid diseases. Outeiro TF; Muchowski PJ J Mol Neurosci; 2004; 23(1-2):49-60. PubMed ID: 15126692 [TBL] [Abstract][Full Text] [Related]
22. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases. Outeiro TF; Giorgini F Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706 [TBL] [Abstract][Full Text] [Related]
23. Oxidative stress and neurodegeneration: the yeast model system. Breitenbach M; Ralser M; Perrone GG; Iglseder B; Rinnerthaler M; Dawes IW Front Biosci (Landmark Ed); 2013 Jun; 18(3):1174-93. PubMed ID: 23747875 [TBL] [Abstract][Full Text] [Related]
25. [Yeast as a model for studying neurodegeneration]. Wawrzycka D Postepy Hig Med Dosw (Online); 2011 Jun; 65():328-37. PubMed ID: 21677357 [TBL] [Abstract][Full Text] [Related]
27. Yeast as a model for the identification of novel survival-promoting compounds applicable to treat degenerative diseases. Verbandt S; Cammue BPA; Thevissen K Mech Ageing Dev; 2017 Jan; 161(Pt B):306-316. PubMed ID: 27287065 [TBL] [Abstract][Full Text] [Related]
28. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview. Ahmad K; Baig MH; Mushtaq G; Kamal MA; Greig NH; Choi I Curr Alzheimer Res; 2017; 14(11):1190-1197. PubMed ID: 28164765 [TBL] [Abstract][Full Text] [Related]
29. Yeast Models and Molecular Mechanisms of Neurodegenerative Diseases. Kaminska J; Zoladek T Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445483 [TBL] [Abstract][Full Text] [Related]
30. Yeast as a model for studying human neurodegenerative disorders. Miller-Fleming L; Giorgini F; Outeiro TF Biotechnol J; 2008 Mar; 3(3):325-38. PubMed ID: 18228539 [TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms controlling sensitivity to toxic metal ions in yeast. Perego P; Howell SB Toxicol Appl Pharmacol; 1997 Dec; 147(2):312-8. PubMed ID: 9439726 [TBL] [Abstract][Full Text] [Related]
32. Genes and the environment in neurodegeneration. Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001 [TBL] [Abstract][Full Text] [Related]
33. Contribution of yeast models to neurodegeneration research. Pereira C; Bessa C; Soares J; Leão M; Saraiva L J Biomed Biotechnol; 2012; 2012():941232. PubMed ID: 22910375 [TBL] [Abstract][Full Text] [Related]
34. Decapping reaction of mRNA requires Dcp1 in fission yeast: its characterization in different species from yeast to human. Sakuno T; Araki Y; Ohya Y; Kofuji S; Takahashi S; Hoshino S; Katada T J Biochem; 2004 Dec; 136(6):805-12. PubMed ID: 15671491 [TBL] [Abstract][Full Text] [Related]
36. From Alzheimer to Huntington: why is a structural understanding so difficult? Temussi PA; Masino L; Pastore A EMBO J; 2003 Feb; 22(3):355-61. PubMed ID: 12554637 [TBL] [Abstract][Full Text] [Related]
37. Methods of assaying Bcl-2 and Bax family proteins in yeast. Xu Q; Jürgensmeier JM; Reed JC Methods; 1999 Apr; 17(4):292-304. PubMed ID: 10196100 [TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of regulatory transcription factors in Schizosaccharomyces pombe and budding yeasts. Beskow A; Wright AP Yeast; 2006 Oct; 23(13):929-35. PubMed ID: 17072884 [TBL] [Abstract][Full Text] [Related]